Data updated: Mar 10, 2026
HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9%
HEPARIN SODIUM
Approved 1984-01-31
2
Indications
--
Phase 3 Trials
42
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1984-01-31
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9% Approval History
Loading approval history...
What HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9% Treats
2 FDA approvalsOriginally approved for its first indication in 1984 . Covers 2 distinct patient populations.
- Other (2)
Other
(2 approvals)- • Approved indication (Jan 1984)
- • Approved indication (Jun 1989)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9% FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.